Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2015

Apr 29, 2015

5229_dirs_2015-04-29_14becf4a-94ae-41d7-9841-564ddc0413f1.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7608L

AstraZeneca PLC

29 April 2015

Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

The following individuals, who are all Directors of the Company, have notified us that they have purchased AstraZeneca PLC Ordinary Shares of $0.25 each or AstraZeneca American Depositary Shares (ADSs).

One AstraZeneca ADS equals one AstraZeneca PLC Ordinary Share of $0.25.

Name of Director Date of notification Date of purchase Number of shares purchased Purchase price
Bruce Burlington 28 April 2015 27 April 2015 600 $71.03
Graham Chipchase 28 April 2015 28 April 2015 1,100 4606p
Shriti Vadera 29 April 2015 29 April 2015 3,500 4563p

A C N Kemp

Company Secretary

29 April 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUKUNRVSASUAR